by Don McLean | Aug 29, 2019 | Blog
Pharmaceutical Industry News Roundup: August 2019 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: Former FDA commissioners seek to expand use of RWE in regulatory...
by Don McLean | Aug 15, 2019 | Blog
Recommended Reading from Eight Pharmaceutical Experts This Summer by Staff Writer Summer reading isn’t reserved for school-aged children, as adults and professionals alike can gain knowledge and insights from consistently reading material during the hottest months of...
by Don McLean | Jul 25, 2019 | Blog
Pharmaceutical Industry News Roundup: July 2019 by Staff writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: Score: Data-sharing practices improve after public...
by Don McLean | Jun 27, 2019 | Blog
Pharmaceutical Industry News Roundup: June 2019 by Staff writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: FDA ‘open for business’ in considering real-world evidence,...
by Don McLean | Jun 13, 2019 | Blog
Developing Treatments for Rare Diseases – Reviewing Draft Guidance from the FDA by Amanda Beaster, PhD, Andrew Chervenak, PhD, Halina Chkourko Gusky, PhD, and Ingrid Hansen, MS New and updated regulatory guidances from the US Food and Drug Administration (FDA),...
